Ko Daniel W., Senior Principal and Portfolio Manager of ECC, demonstrates confidence in the company by purchasing 57,165 shares, increasing his total holdings significantly. ECC's stock price reflect...
Spire Global reported an earnings per share (EPS)...
Roger Song from Jefferies sets a price target of ...
Earnings per Share (EPS) of $0.27, slightly below estimates. Revenue reported at approximately $297.1 million, missing estimates. Financial Health indicated by a low debt-to-equity ratio and a strong
Alibaba (NYSE:BABA) is set to release its quarterly earnings with an expected EPS of $1.57 and revenue of around $42.1 billion. The company is increasing its AI and computing storage prices by up to
Alex Scott from Barclays sets a price target of $247 for NYSE:PGR, indicating a potential upside of approximately 21.8%. The stock's current trading price is $202.80, with a year's trading range betw
Protalix BioTherapeutics, Inc. (AMEX:PLX) received European Commission approval for Elfabrio®, enhancing its financial position with a $25 million milestone payment. The company reported an earnings
Ovid Therapeutics Inc. (NASDAQ:OVID) Surpasses Earnings and Revenue Estimates Ovid Therapeutics Inc. (NASDAQ:OVID) reported earnings per share of $0.06 for Q4 2025, beating the estimated loss of $0.1
Earnings Per Share (EPS) matched the Zacks Consensus Estimate at $0.08, showing a significant improvement from the previous year. Revenue for the quarter was $294.65 million, surpassing estimates and
